Alnylam Pharmaceuticals

RNA interference (RNAi) is a naturally occurring process of gene regulation that is already at work inside your body. RNAi therapeutics, which were pioneered by Alnylam, utilize this process to silence the genes that cause or contribute to disease. #ScienceCurious to learn more about #RNAi? Click here: https://bit.ly/3oR8r2l #RNAiTherapeutics #siRNA #GeneSilencing #RNA

As a pioneer in RNA-based therapeutics, we relish the opportunity to engage with peers and discuss what's new and next in nucleic acid medicines. If you do too, join us and co-organizers Nature Biotechnology, Ionis Pharmaceuticals, Inc. and UC San Diego School of Medicine at the #RNAbench2bedside conference happening Dec 9-11. Learn more: https://lnkd.in/e5DmnhGA and submit an abstract through Oct 9: https://bit.ly/3WJddzQ #RNA #RNAi #RNAinterference #RNAiTherapeutics #siRNA

We’re harnessing the potential of RNA interference (RNAi) and will be presenting new data at the European Society of Cardiology Congress 2024 8/30-9/2 in London. Learn more: https://bit.ly/3X4wxZL

Happy #RNAday! RNA is truly A-mazing. It’s responsible for many things but primary among them is facilitating protein synthesis - the process by which your body makes new proteins, which are the "workers" in the biochemistry of life. But sometimes, faulty proteins, or too much of a protein, can cause or contribute to disease. Fortunately, a type of RNA can be used to treat disease! RNA interference (RNAi) therapeutics utilize small interfering RNA (siRNA) to prevent the production of these unwanted proteins. Watch this video to learn how. #ScienceCurious to learn even more? Click here: https://bit.ly/3oR8r2l #RNA #RNAi #RNAinterference #RNAiTherapeutics #siRNA #science

We've reported Q2 2024 financial results and highlights of recent period activity. Join us LIVE TODAY at 8:30 AM ET to hear from our leadership and/or access the replay later today at: https://bit.ly/374c75E. Read the Q2 2024 financial results press release: https://bit.ly/4dpnec6 #RNAi #RNAiTherapeutics #siRNA

We'll be sharing 2nd Quarter 2024 financial results this Thursday, 8/1 at 8:30 AM ET, during a LIVE webcast. Register here: https://bit.ly/374c75E and access the replay at the same link later in the day. #RNAi #RNAitherapeutics #siRNA

It's #NationalInternDay and we're celebrating the contributions of our #interns who represent the incredible potential of the next generation of #biopharma professionals! We believe that the seeds of tomorrow's breakthroughs are planted today through inclusive programs that provide opportunities to early career individuals from diverse backgrounds, including those who come to us from our partner Project Onramp. You can learn more about our Internship program here: https://bit.ly/3W6LHM8

Innovative science is only part of the equation when it comes to developing new medicines. Clinical research relies on partnerships with health care professionals and patient advocates but most importantly, the people who choose to participate in #ClinicalTrials. Learn more about Alnylam's clinical trials: https://bit.ly/35jLcrU

Alnylam's corporate responsibility efforts are driven by the passion of our employees to make a positive impact on the world beyond the medicines we make. Whether it's at work or in communities across the globe, their dedication to doing good is evident every day. Our 2023 Corporate Responsibility Report details our work, shares our progress, reflects our commitment to accountability, and looks ahead to what we aim to accomplish in the years to come. Learn more and download the report: https://bit.ly/3UoMUO2 #ESG #CorporateResponsibility #CSR

Earning a spot on Fortune's Best Workplace for Millennials list two years in a row? That's something to be #AlnylamProud of! We know our success and ability to deliver innovative new medicines to patients is made possible by the strength of our culture and the important contribution of all of our employees, including our millennial colleagues! Learn more and see the list: https://bit.ly/4d71TDQ. #CompanyCulture #GreatPlaceToWork #BestWorkplaces Great Place To Work US